AP
The startup develops high-end generic drugs through advanced research and development of various dosage forms, including tablets, capsules, and injections, targeting anti-infective, anti-tumor, neuropsychiatric, and chronic disease treatments. By enhancing the formulation and delivery of these medications, the company aims to improve treatment efficiency for healthcare providers and patients.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops high-end generic drugs through advanced research and development of various dosage forms, including tablets, capsules, and injections, targeting anti-infective, anti-tumor, neuropsychiatric, and chronic disease treatments. By enhancing the formulation and delivery of these medications, the company aims to improve treatment efficiency for healthcare providers and patients.